David B Whitman

Title: David B. Whitman: Innovator in Fatty Acid Synthase Inhibition

Introduction

David B. Whitman is a notable inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit fatty acid synthase.

Latest Patents

Whitman holds a patent for spiropiperidine derivatives. This patent describes spiropiperidine compounds that have demonstrated activity as fatty acid synthase inhibitors. The patent also details pharmaceutical compositions containing these spiropiperidine compounds and methods for treating diseases mediated by fatty acid synthase. Additionally, it outlines methods for synthesizing these compounds, including synthetic intermediates useful in their production.

Career Highlights

David B. Whitman has worked at Cephalon, Inc., where he has been involved in innovative research and development. His work has contributed to advancements in pharmaceutical formulations and therapeutic methods.

Collaborations

Whitman has collaborated with notable colleagues, including Robert L. Hudkins and Craig A. Zificsak, enhancing the research and development efforts at Cephalon, Inc.

Conclusion

David B. Whitman is a distinguished inventor whose work in spiropiperidine derivatives has the potential to impact the treatment of diseases related to fatty acid synthase. His contributions to pharmaceutical chemistry are noteworthy and continue to influence the field.